Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ittmann

Showing results (21-30 of 125) with videos related to

Pageof 13
Sort By:
The Prostate|December 16, 2003
Chronic activity of ectopic type 1 fibroblast growth factor receptor tyrosine kinase in prostate epithelium results in hyperplasia accompanied by intraepithelial neoplasiaFen Wang, Kerstin McKeehan, Chundong Yu, et al.
Oncotarget|May 29, 2015
FGF23 promotes prostate cancer progressionShu Feng, Jianghua Wang, Yiqun Zhang, et al.
Human Pathology|March 17, 2017
Cellular interactions of the phosphorylated form of AKT in prostate cancerKai H Hammerich, Anna Frolov, Rile Li, et al.
International Journal of Cancer|October 6, 2005
PSGR2, a novel G-protein coupled receptor, is overexpressed in human prostate cancerJinsheng Weng, Jianghua Wang, Xiaoxiao Hu, et al.
Cancer Research|January 30, 2009
GGAP2/PIKE-a directly activates both the Akt and nuclear factor-kappaB pathways and promotes prostate cancer progressionYi Cai, Jianghua Wang, Rile Li, et al.
The Prostate|December 29, 2015
The role of ATP-binding cassette transporter genes in the progression of prostate cancerOmer F Karatas, Esra Guzel, Mehmet B Duz, et al.
The Prostate|February 24, 2006
The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemaseJianghua Wang, Jinsheng Weng, Yi Cai, et al.
Endocrine-Related Cancer|May 15, 2015
Expression of ERG protein in prostate cancer: variability and biological correlatesGustavo Ayala, Anna Frolov, Deyali Chatterjee, et al.
The Prostate|October 16, 2019
Targeting the TMPRSS2/ERG fusion mRNA using liposomal nanovectors enhances docetaxel treatment in prostate cancerLongjiang Shao, Nermin Kahraman, Ge Yan, et al.
Stem Cells (Dayton, Ohio)|June 3, 2010
Dicer ablation impairs prostate stem cell activity and causes prostate atrophyLi Zhang, Boyu Zhang, Joseph M Valdez, et al.
Pageof 13

Showing results (21-30 of 125) with videos related to

Sort By:
Pageof 13
The Prostate|December 16, 2003
Chronic activity of ectopic type 1 fibroblast growth factor receptor tyrosine kinase in prostate epithelium results in hyperplasia accompanied by intraepithelial neoplasiaFen Wang, Kerstin McKeehan, Chundong Yu, et al.
Oncotarget|May 29, 2015
FGF23 promotes prostate cancer progressionShu Feng, Jianghua Wang, Yiqun Zhang, et al.
Human Pathology|March 17, 2017
Cellular interactions of the phosphorylated form of AKT in prostate cancerKai H Hammerich, Anna Frolov, Rile Li, et al.
International Journal of Cancer|October 6, 2005
PSGR2, a novel G-protein coupled receptor, is overexpressed in human prostate cancerJinsheng Weng, Jianghua Wang, Xiaoxiao Hu, et al.
Cancer Research|January 30, 2009
GGAP2/PIKE-a directly activates both the Akt and nuclear factor-kappaB pathways and promotes prostate cancer progressionYi Cai, Jianghua Wang, Rile Li, et al.
The Prostate|December 29, 2015
The role of ATP-binding cassette transporter genes in the progression of prostate cancerOmer F Karatas, Esra Guzel, Mehmet B Duz, et al.
The Prostate|February 24, 2006
The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemaseJianghua Wang, Jinsheng Weng, Yi Cai, et al.
Endocrine-Related Cancer|May 15, 2015
Expression of ERG protein in prostate cancer: variability and biological correlatesGustavo Ayala, Anna Frolov, Deyali Chatterjee, et al.
The Prostate|October 16, 2019
Targeting the TMPRSS2/ERG fusion mRNA using liposomal nanovectors enhances docetaxel treatment in prostate cancerLongjiang Shao, Nermin Kahraman, Ge Yan, et al.
Stem Cells (Dayton, Ohio)|June 3, 2010
Dicer ablation impairs prostate stem cell activity and causes prostate atrophyLi Zhang, Boyu Zhang, Joseph M Valdez, et al.
Pageof 13